Leadership
To pursue a mission like GRAIL’s, it takes all of us—a unified collective of innovative and data-driven thinkers dedicated to creating a better world. Our leadership teams bring together diverse expertise across science, medicine, technology, and business, united by a shared commitment to advancing early cancer detection and transforming outcomes for patients.
Leadership Team
Joshua Ofman, MD, MSHS
Chief Executive Officer
Satnam Alag, PhD
Senior Vice President, Software Engineering and Chief Security Officer
Abram Barth JD, MPH
Chief Legal Officer
Paul Ciccolella
Senior Vice President, Global Development & Operations
Aaron Freidin
Chief Financial Officer & Head of Corporate Development
Eric Fung
Senior Vice President, Clinical Development
Alison Highlander
Senior Vice President, Human Resources; Head of People Team
Sir Harpal Kumar
Chief Scientific Officer & President, Global Clinical and Medical Affairs
Andy Partridge
Chief Growth Officer
Erin Polak
Senior Vice President, Government Affairs, Policy, and Alliance Development
Trish Rowland
Senior Vice President, Corporate Communications
Oliver Venn, PhD
Senior Vice President, Research
Distinguished Scientists
Christina Clarke Dur
Vice President, Epidemiology and Distinguished Scientist
Megan Hall, PhD
Vice President, Medical Affairs
Earl Hubbell, PhD
Distinguished Scientist and Vice President
Eric A. Klein, MD
Distinguished Scientist
Board of Directors
Gregory (Greg) Summe
Chair of the Board, Chair of Nominating and Governance Committee, Member of Audit Committee and Compensation Committee
Joshua Ofman, MD, MSHS
Chief Executive Officer
Sarah Krevans
Member of the Audit Committee, Compensation Committee, and Nominating and Governance Committee
Steve Mizell
Chair of Compensation Committee, Member of Audit Committee and Nominating and Governance Committee
William (Bill) Chase
Chair of Audit Committee, Member of Compensation Committee and Nominating and Governance Committee